PacBio encourages investors to carefully consider its results under GAAP, as well as its supplemental non‐GAAP information and the reconciliation between these presentations, to more fully ...

Good afternoon and welcome to PacBio fourth quarter of 2024 earnings ... A copy of our earnings presentation is also available on the investors section of our website. With me today are Christian ...

Pacific Biosciences of California emphasized its strategic focus on expanding HiFi sequencing through product innovations like Vega and Revio. While macroeconomic uncertainties and academic ...

PacBio (PACB) announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option covering 400,000 shares of PacBio common stock, and restricted ...

Pacific Biosciences of California ... A copy of our earnings presentation is also available on the Investors section of our website. With me today are Christian Henry, President and Chief ...

Loss on extinguishment of debt is related to the exchange of a portion of PacBio's 1.50% Convertible Senior Notes due 2028 for PacBio's 1.375% Convertible Senior Notes due 2030. Gain on debt ...

MENLO PARK, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation ...

Good day. And welcome to the PacBio Fourth Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be ...